Active — Not RecruitingPhase 2

HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

China210 participantsStarted 2025-10-31

Plain-language summary

This study plans to enroll a total of 208 patients with Acute Ischemic Stroke (AIS) who present within 4.5 to 24 hours of symptom onset and meet the specified imaging criteria.

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Fully understand and voluntarily participate in this study, and sign the informed consent form;
. Aged between 18 and 80 years inclusive (18 ≤ age ≤ 80), regardless of gender;
. Onset of symptoms within 4.5 to 24 hours;
. Clinically diagnosed with acute ischemic stroke;
. Pre-stroke modified Rankin Scale (mRS) score \< 2;
. National Institutes of Health Stroke Scale (NIHSS) score between 6 and 25 (inclusive) at screening;
. Meet the imaging inclusion criteria;
. Female subjects of childbearing potential and male subjects with partners of childbearing potential must use highly effective contraception and avoid sperm/ova donation.

Exclusion criteria

. Treatment with thrombolytic therapy.
. Planned endovascular therapy.
. Arterial dissection of the head, neck, or aorta.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

mRS score of 0-1 at 90 days

Timeframe: within 90 days after the start of administration

Trial details

NCT IDNCT07233070

SponsorFujian Shengdi Pharmaceutical Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-10

View on ClinicalTrials.gov More Acute Ischemic Stroke trials